
Peter K. Huntsinger
Examiner (ID: 6501, Phone: (571)272-7435 , Office: P/2673 )
| Most Active Art Unit | 2625 |
| Art Unit(s) | 2625, 2674, 2624, 2671, 2615, 2682, 2673 |
| Total Applications | 456 |
| Issued Applications | 130 |
| Pending Applications | 85 |
| Abandoned Applications | 262 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5921543
[patent_doc_number] => 20060240073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Structure of modulating intraocular pressure on glaucoma'
[patent_app_type] => utility
[patent_app_number] => 11/471695
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5051
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240073.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471695
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471695 | Structure of modulating intraocular pressure on glaucoma | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5237132
[patent_doc_number] => 20070129289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them'
[patent_app_type] => utility
[patent_app_number] => 11/455937
[patent_app_country] => US
[patent_app_date] => 2006-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 18378
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20070129289.pdf
[firstpage_image] =>[orig_patent_app_number] => 11455937
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/455937 | Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them | Jun 19, 2006 | Issued |
Array
(
[id] => 5786440
[patent_doc_number] => 20060205661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Novel albumin-free factor VIII formulations'
[patent_app_type] => utility
[patent_app_number] => 11/434634
[patent_app_country] => US
[patent_app_date] => 2006-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7433
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205661.pdf
[firstpage_image] =>[orig_patent_app_number] => 11434634
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/434634 | Albumin-free factor VIII formulations | May 14, 2006 | Issued |
Array
(
[id] => 5160400
[patent_doc_number] => 20070173444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'PEPTIDES AND COMPOUNDS THAT BIND TO THE IL-5 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 11/381172
[patent_app_country] => US
[patent_app_date] => 2006-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18788
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20070173444.pdf
[firstpage_image] =>[orig_patent_app_number] => 11381172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/381172 | Peptides and compounds that bind to the IL-5 receptor | May 1, 2006 | Issued |
Array
(
[id] => 344836
[patent_doc_number] => 07498021
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-03-03
[patent_title] => 'Dental products comprising bone growth enhancing peptide'
[patent_app_type] => utility
[patent_app_number] => 11/379316
[patent_app_country] => US
[patent_app_date] => 2006-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 5946
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/498/07498021.pdf
[firstpage_image] =>[orig_patent_app_number] => 11379316
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/379316 | Dental products comprising bone growth enhancing peptide | Apr 18, 2006 | Issued |
Array
(
[id] => 5851742
[patent_doc_number] => 20060234933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'VASOACTIVE INTESTINAL POLYPEPTIDE PHARMACEUTICALS'
[patent_app_type] => utility
[patent_app_number] => 11/279238
[patent_app_country] => US
[patent_app_date] => 2006-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14044
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234933.pdf
[firstpage_image] =>[orig_patent_app_number] => 11279238
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/279238 | Vasoactive intestinal polypeptide pharmaceuticals | Apr 9, 2006 | Issued |
Array
(
[id] => 5875198
[patent_doc_number] => 20060166896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Novel indazole peptidomimetics as thrombin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/393350
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10836
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166896.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393350
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393350 | Novel indazole peptidomimetics as thrombin receptor antagonists | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5875199
[patent_doc_number] => 20060166897
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Novel indazole peptidomimetics as thrombin receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/393529
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10837
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166897.pdf
[firstpage_image] =>[orig_patent_app_number] => 11393529
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/393529 | Indazole peptidomimetics as thrombin receptor antagonists | Mar 29, 2006 | Issued |
Array
(
[id] => 5672954
[patent_doc_number] => 20060178309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Method for the crystallization of human serum albumin'
[patent_app_type] => utility
[patent_app_number] => 11/378727
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 19488
[patent_no_of_claims] => 131
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20060178309.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378727
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378727 | Method for the crystallization of human serum albumin | Mar 16, 2006 | Abandoned |
Array
(
[id] => 5852014
[patent_doc_number] => 20060235205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Process for preparing porous collagen matrix from connective tissue'
[patent_app_type] => utility
[patent_app_number] => 11/371323
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4460
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20060235205.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371323
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371323 | Process for preparing porous collagen matrix from connective tissue | Mar 7, 2006 | Issued |
Array
(
[id] => 5913565
[patent_doc_number] => 20060128627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Human appetite control by glucagon-like peptide receptor binding compounds'
[patent_app_type] => utility
[patent_app_number] => 11/348148
[patent_app_country] => US
[patent_app_date] => 2006-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6840
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128627.pdf
[firstpage_image] =>[orig_patent_app_number] => 11348148
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/348148 | Human appetite control by glucagon-like peptide receptor binding compounds | Feb 5, 2006 | Abandoned |
Array
(
[id] => 307446
[patent_doc_number] => 07531512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-05-12
[patent_title] => 'Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/346395
[patent_app_country] => US
[patent_app_date] => 2006-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6417
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/531/07531512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11346395
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/346395 | Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes | Feb 2, 2006 | Issued |
Array
(
[id] => 5630941
[patent_doc_number] => 20060147409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Biocompatible crosslinked polymers with visualization agents'
[patent_app_type] => utility
[patent_app_number] => 11/293892
[patent_app_country] => US
[patent_app_date] => 2005-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18864
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20060147409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11293892
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/293892 | Biocompatible crosslinked polymers with visualization agents | Dec 1, 2005 | Issued |
Array
(
[id] => 185114
[patent_doc_number] => 07648965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-19
[patent_title] => 'Method for fostering bone formation and preservation'
[patent_app_type] => utility
[patent_app_number] => 11/267987
[patent_app_country] => US
[patent_app_date] => 2005-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13939
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/648/07648965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267987
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267987 | Method for fostering bone formation and preservation | Nov 6, 2005 | Issued |
Array
(
[id] => 5716093
[patent_doc_number] => 20060079456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Vasoactive intestinal polypeptide pharmaceuticals'
[patent_app_type] => utility
[patent_app_number] => 11/245499
[patent_app_country] => US
[patent_app_date] => 2005-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10785
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079456.pdf
[firstpage_image] =>[orig_patent_app_number] => 11245499
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/245499 | Vasoactive intestinal polypeptide pharmaceuticals | Oct 6, 2005 | Issued |
Array
(
[id] => 506385
[patent_doc_number] => 07202341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-10
[patent_title] => 'Stabilized hemoglobin solutions'
[patent_app_type] => utility
[patent_app_number] => 11/231921
[patent_app_country] => US
[patent_app_date] => 2005-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 11308
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/202/07202341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11231921
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/231921 | Stabilized hemoglobin solutions | Sep 20, 2005 | Issued |
Array
(
[id] => 5596825
[patent_doc_number] => 20060160743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Peptides that selectively home to heart vasculature and related conjugates and methods'
[patent_app_type] => utility
[patent_app_number] => 11/222370
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 28248
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160743.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222370
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222370 | Peptides that selectively home to heart vasculature and related conjugates and methods | Sep 6, 2005 | Issued |
Array
(
[id] => 5619982
[patent_doc_number] => 20060189516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Method for producing cross-linked hyaluronic acid-protein bio-composites'
[patent_app_type] => utility
[patent_app_number] => 11/208596
[patent_app_country] => US
[patent_app_date] => 2005-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13505
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189516.pdf
[firstpage_image] =>[orig_patent_app_number] => 11208596
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/208596 | Method for producing cross-linked hyaluronic acid-protein bio-composites | Aug 22, 2005 | Abandoned |
Array
(
[id] => 5807270
[patent_doc_number] => 20060093624
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Botulinum toxin for treating muscle contracture'
[patent_app_type] => utility
[patent_app_number] => 11/209304
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5142
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093624.pdf
[firstpage_image] =>[orig_patent_app_number] => 11209304
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/209304 | Botulinum toxin for treating muscle contracture | Aug 21, 2005 | Issued |
Array
(
[id] => 5672063
[patent_doc_number] => 20060177417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Pharmaceutical formulations for sustained drug delivery'
[patent_app_type] => utility
[patent_app_number] => 11/205292
[patent_app_country] => US
[patent_app_date] => 2005-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6985
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11205292
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/205292 | Pharmaceutical formulations for sustained drug delivery | Aug 14, 2005 | Abandoned |